A comprehensive review of advanced biopolymeric wound healing systems

Journal of Pharmaceutical Sciences

Volumn 103, Issue 8, 2014, Pages 2211-2230

  Mayet, Naeema ^a   Choonara, Yahya E ^a   Kumar, Pradeep ^a   Tomar, Lomas K ^a   Tyagi, Charu ^a   Du Toit, Lisa C ^a   Pillay, Viness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

bioactive agents; extracellular matrix (ECM); hydrogels; nanotechnology; polymeric biomaterials; skin; tissue engineering; wound dressings; wound healing

Indexed keywords

ALGINIC ACID; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIOXIDANT; BIOMATERIAL; BIOPOLYMER; CADEXOMER IODINE; CHITOSAN; CHLORHEXIDINE; COLLAGEN; CONNEXIN 43; CYTOKINE; EPIDERMAL GROWTH FACTOR; HYDROGEN PEROXIDE; KETOTIFEN; MOLECULAR SCAFFOLD; NANOPARTICLE; NANOMATERIAL; POLYMER;

BIOCOMPATIBILITY; CELL FUNCTION; DRUG DELIVERY SYSTEM; FIBROBLAST; GAP JUNCTION; GAS EXCHANGE; GENE THERAPY; HUMAN; HYDROCOLLOID DRESSING; HYDROGEL; LYOPHILISED WAFER; MACROPHAGE; MICROBIAL ACTIVITY; NANOTECHNOLOGY; NONHUMAN; REVIEW; SKIN INJURY; STEM CELL; TISSUE REGENERATION; WOUND CARE; WOUND DRESSING; WOUND FLUID; WOUND HEALING; ANIMAL; BANDAGE; BIOLOGICAL THERAPY; CHEMISTRY; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; NANOMEDICINE;

ANIMALS; BANDAGES; BIOCOMPATIBLE MATERIALS; CELL- AND TISSUE-BASED THERAPY; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOSTRUCTURES; POLYMERS; SKIN PHYSIOLOGICAL PHENOMENA; WOUND HEALING;

EID: 84905107537     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24068     Document Type: Review

References (170)

1. Shi J, Alexandra R, Votruba S, Omid C, Farokhzad S, Langer R,. 2010. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett 10: 3223-3230.
2. Biondi M, Ungaro F, Quaglia F, Netti PA,. 2008. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 60: 229-242.
3. Goldberg M, Langer R, Xinqiao J,. 2007. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym 18: 241-268.
4. Broudriot U, Dersh R, Griener A, Wendorff JH,. 2006. Electrospinning approaches toward scaffold engineering-A brief overview. Artif Organs 30: 785-792.
5. Patzke GR, Krumeich F, Nesper R,. 2002. Oxidic nanotubes and nanorods-Anisotropic modules for a future nanotechnology. Angew Chem Int Ed 41: 2446-2461.
6. Cross-section of skin. Accessed June 6, 2014, at: http://www.infovisual. info/0./0.36-en.html.
7. Chong EJ, Phan TT, Lim IJ, Zhang YZ, Bay BH, Ramakrishna S, Lim CT,. 2007. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomater 3: 321-330.
8. Zhong SP, Zhang YZ, Lim CT,. 2010. Tissue scaffolds for skin wound healing and dermal reconstruction. Nanomed Nanobiotechnol 2: 510-525.
9. Cohen S,. 1983. The epidermal growth factor (EGF). Cancer 51: 1787-1791.
10. Boateng JS, Matthews KH, Stevens NE, Eccleston GM,. 2008. Wound healing dressings and drug delivery systems: A review. J Pharm Sci 97: 2892-2923.
11. Shanmagasundaram N, Sundaraseelan J, Uma S, Selvaraj D, Babu M,. 2005. Design and delivery of silver sulphadiazine from alginate microspheres impregnated collagen scaffolds. J Biomed Mater Res Appl Biomater 77B: 278-388.
12. Mallefet P, Dweck AC,. 2008. Mechanism involved in wound healing. Biomed Scientist 7: 609-615.
13. Madhumathi K, Kumar PTS, Apilash S, Sreeja V, Tamura H, Manzoor K, Nair SV, Jayakumar R,. 2010. Development of novel chitin nanosilver composite scaffolds for wound dressing applications. J Mater Sci Mater Med 21: 807-813.
14. Adam singer A, Richard AF, Clark MD,. 1999. Cutaneous wound healing. New Engl J Med 341: 738-746.
15. Sibbald GR, Orsted H, Schultz GS, Coutts P, Keast D,. 2003. Preparing the wound bed 2003, Focus on infection and inflammation. Ostomy Wound Manag 49: 24-51.
16. Dulmovits BM, Herman IM,. 2012. Microvascular remodelling and wound healing: A role for pericytes. Int J Biochem Cell Biol 44: 1800-1812.
17. Stein C, Kuchler S,. 2013. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci 34: 303-312.
18. Jannesari M, Varshosaz J, Morshed M, Zamani M,. 2011. Composite poly(vinyl alcohol) /poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs. Int J Nanomed 6: 993-1003.
19. Schultz GS, Barillo DJ, Mozingo DW, Chin GA,. 2004. Wound bed preparations and a brief history of time. Int Wound J 1: 19-32.
20. Bindu TVL, Vidyavathi M, Kavitha K, Sastry TP, Kumar S, RV,. 2010. Preparation and evaluation of chitosan-gelatin composite films for wound healing activity. Trends Biomater Artif Organs 24: 123-130.
21. Granick M, Boykin J, Gamelli R, Schultz G, Tenenhaus M,. 2006. Toward a common language: Surgical wound bed preparation and debridgement. Wound Rep Reg 14: S1-S10.
22. Lloyd LL, Kennedy JF, Methacanon P, Paterson M, Knill CJ,. 1998. Carbohydrate polymers as wound management aids. Carbohydr Polym 37: 315-322.
23. Schultz GS, Sibbald GR, Falanga V, Yello EEA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W,. 2003. Wound bed preparation, a systemic approach to wound management. Wound Rep Reg 11: 1-28.
24. Parsons D, Bowler PG, Myles V, Jones S,. 2005. Silver antimicrobial dressings in wound management, a comparison of anti-bacterial physical and chemical characteristics. Wounds 17: 222-232.
25. Chambers CW, Proctor CM, Kabler PW,. 1962. Bactericidal effect of low concentrations of silver. J Am Water Works Assoc 54: 208-216.
26. Brook I,. 1996. Microbilogy and management of sinusitis. J Otolaryngol 25: 249-256.
27. Bowler PG, Davies B,. 1999. The microbiology of infected and noninfected leg ulcers. Int J Dermatol 38: 573-578.
28. Canal C, Gaboriou F, Villeger S, Cvelbar U, Ricard A,. 2009. Studies of antibacterial dressings obtained by fluorinated post-discharge plasma. Int J Pharm 367: 155-161.
29. Falanga V,. 1988. Occlusive wound dressings: Why, when, which ? Arch Dermatol 124: 872-877.
30. Kallaiinen LK, Gordillo GM, Schlanger RK, Sen C,. 2003. Topical oxygen as adjunct to wound healing, a clinical case series. Pathophysiology 9: 208-216.
31. Lloyd AW,. 2002. Interfacial bioengineering to enhance surface biocompatibility. Med Device Technol 13: 18-21.
32. Ruszczak Z,. 2003. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55: 1595-1611.
33. Atiyeh BS, Ioannovich J, Al-Amm CA, El-Musa KA,. 2002. Management of acute and chronic open wounds: The importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 3: 179-195.
34. Paul W, Sharma CP,. 2004. Chitosan and alginate wound dressings: A short review. Trends Biomater Artif Organs 18: 18-23.
35. Kim TG, Park TG,. 2006. Biomimicking extracellular matrix: Cell adhesive RGD peptide modified electrospun poly (D, L-lactic-co-glycolic acid) nanofiber mesh. Tissue Eng 12: 221-233.
36. Sill TJ, von Rectum HA,. 2006. Electrospinning: Applications in drug and tissue engineering. Biomaterials 29: 1989-2006.
37. Duncan R,. 2003. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2: 347-360.
38. Brocchini S, Duncan R,. 1999. Encyclopaedia of controlled drug delivery;, Mathiowitz, E, Ed. New York, NY: Wiley, pp 786-816.
39. Qiu LY, Bae YH,. 2006. Polymer architecture and drug delivery. Pharm Res 23: 1-30.
40. Moura LIF, Dias AMA, Carvalho E, de Sousa HC,. 2013. Recent advances on the development of wound dressing s for diabetic foot ulcer treatment-A review. Acta Biomater 9: 7093-7114.
41. Tabata Y,. 2009. Biomaterial technology for tissue engineering applications. J R Soc Interface 6: S311-S24.
42. Sell SA, Wolfe PS, Garg K, McCool JM, Rodiguez IA, Bowlin GL,. 2010. The use of natural polymers in tissue engineering: A focus on electrospun extracellular matrix analogues. Polym Adv Technol 2: 522-553.
43. Malafaya PB, Silver GA, Reis RL,. 2007. Natural origin polymers as carriers and scaffolds for biomolecules and all delivery in tissue engineering applications. Adv Drug Deliv Rev 59: 207-233.
44. Balakrishan B, Mohanty M, Fernandez AC, Moharan PV, Jayakrishnan A,. 2006. Evaluation of the effect of incorporation of dibutyryl cyclic adenosine monophosphate in an in-situ forming hydrogel wound dressing based on oxidised alginate and gelatine. Biomaterials 27: 1355-1361.
45. Livesey SA, Herndon DN, Hollyoak MA, Atkinson YH, Nag A,. 1995. Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of a viable dermis. Transplantation 60: 1-9.
46. Melcalfe AD, Ferguson MWJ,. 2007. Tissue engineering of replacement skin: The crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 4: 413-437.
47. Duo T, Tanaka M, Huang YY, Hamblin MR,. 2011. Chitosan preparations for wounds and burns: Anti-microbial and wound healing effects. Expert Rev Anti Infect Ther 9: 857-879.
48. Perez RA, Won J, Khowles JC, Kim H,. 2012. Naturally and synthetic smart composite biomaterials for tissue regeneration. Adv Drug Deliv Rev 65: 471-496.
49. Bourke SL, Al-Khalili U, Briggs T, Mickniak BB, Kohn J, Poole-Warren LA,. 2003. A photo crosslinked poly(vinyl-alcohol) hydrogel growth factor release vehicle for wound healing applications. AAPS Pharm Sci Tech 5: E33.
50. Kim JO, Park JK, Kim JH, Jin SG, Yong CS, Li DX,. 2008. Development of poly vinyl alcohol-sodium alginate gel matrix based wound dressing system containing nitrofurazone. Int J Pharm 359: 79-86.
51. Lee KY, Mooney DJ,. 2001. Hydrogels for tissue engineering. Chem Rev 101: 1869-1879.
52. Slaughter BV, Shahana SK, Fisher OZ, Khademhasseini A, Peppas NA,. 2009. Hydrogels in regenerative medicine. Adv Mater 21: 3307-3329.
53. Kim IY, Yoo MK, Seo JK, Park SS, Na HS, Lee HC, Kim SK, Cho CS,. 2001. Evaluation of semi-interpenetrating polymer networks composed of chitosan and poloxamer for wound dressing applications. Int J Pharm 341: 35-43.
54. Nair LS, Laurencin CT,. 2007. Biodegradable polymers as biomaterials. Prog Polym Ssci 32: 762-798.
55. Tsao CT, Chang CH, Lin YY, Wu MF, Wang JL, Young TH, Han JL, Hsieh KH,. 2011. Evaluation of chitosan poly (glutamic acid) polyelectrolyte complex for wound dressing materials. Carbohydr Polym 84: 812-819.
56. Jones V, Grey JE, Harding KG,. 2006. ABC of wound healing: Wound dressings. BMJ 332: 777-780.
57. Rayment EA, Dargaville TR, Shooter GK, George GA, Upton Z,. 2008. Attenuation of protease activity in chronic wound fluid with biophonate functionalised hydrogels. Biomaterials 29: 1785-1795.
58. Li X, Nan K, Li L, Zhang Z, Chen H,. 2011. In vivo evaluation of curcumin nanoformulation loaded methoxy poly(ethylene glycol)-graft chitosan film for wound healing applications. Carbohydr Polym 88: 84-90.
59. Pawar HV, Tetteh J, Boatang JS,. 2013. Preparation, optimisation and characterisation of novel wound healing film dressings loaded with streptomycin and diclofenac. Colloid Surf B Biointerface 102: 102-110.
60. Miller MS,. 2009. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers. J Foot Ankle Surg 38: 227-231.
61. Kiwanuka E, Junker J, Eriksson E,. 2012. Harnessing growth factors to influence wound healing. Clin Plastic Surg 39: 239-248.
62. Judith R, Nithya M, Rose C, Mandal AB,. 2010. Application of a PDGF-containing novel gel for cutaneous wound healing. Life Sci 87: 1-8.
63. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H,. 2009. The role of vascular endothelial growth factor in wound healing. J Surg Res 153: 347-358.
64. Hardwicke J, Schmaljohann D, Boyce D, Thomas D,. 2008. Epidermal growth factor therapy and wound healing- fast, present and future perspectives. Surgeon 6: 172-177.
65. Cohen S,. 1983. The epidermal growth factor (EGF). Cancer 51: 1787-1791.
66. Tolino MA, Black ER, Klarland JK,. 2011. Brief treatment with heparin binding EGF-like growth factor, but not with EGF is sufficient to accelerate epithelial wound healing. Biochem Biophys Acta 1810: 875-878.
67. Choi JK, Jang JH, Jang WH, Kim J, Bae IH, Bae J, Park YH, Kim BH, Lim KM, Park JW,. 2012. The effect of epidermal growth factor (EGF) conjugated with ion-molecular-weight protoamine (LMWP) on wound healing of the skin. Biomaterials 33: 8579-8590.
68. Park YJ, Chang LC, Liong JF, Moon C, Chung CP, Yang VC,. 2005. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: In vitro and in vivo study. FASEB J 19: 1555-1557.
69. Gurther GC, Werner S, Barrandon Y, Longaker MT,. 2008. Wound repair and regeneration. Nature 453: 314-321.
70. Robson MC,. 1991. Growth factors as wound healing agents. Current Opt Biotechnol 2: 863-867.
71. Pierce GF, Vandeberg J, Rudolph R, Tarpley S, Mustoe TA,. 1991. Platelet derived growth factor-BB and transforming growth factor beta-1 selectively moderate glycoaminoglycans, collagens and myofibroblasts in excisional wounds. Am J Pathol 138: 629-646.
72. Mustoe TA, Pierce GF, Morishima C, Deuel TF,. 1991. Growth factor induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Dir Invest 87: 694-703.
73. Cromack DT, Porras- Reyes B, Mustoe TA,. 1990. Current concepts in wound healing: Growth factors and macrophage interaction. J Trauma 30: S129-S133.
74. Chen FM, Zhang M, Wu ZF,. 2010. Towards delivery of multiple growth factors in tissue engineering. Biomaterials 31: 6279-6308
75. Carter CA, Jolly DG, Worden Sr CE, Hendren DG, Kane CJM,. 2003. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 74: 244-255.
76. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Moroni M, Carabelli A,. 2004. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30: 145-151
77. Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M,. 2009. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 40: 801-805.
78. Sandri G, Bonferoni MC, Rossi S, Ferrari F, Mori M, Fante CD, Perotti C, Scudeller L, Caramella C,. 2011. Platelet lysate formulations based on mucoadhesive polymers for the treatment of corneal lesions. J Pharm Pharmacol 63: 189-198.
79. Sandri G, Bonferoni MC, Autilia FD, Rossi S, FerrarI F, Grisoli P, Sorrenti M, Catenacci L, Fante CD, Perotti C, Caramella C,. 2013. Wound dressings based on silver sulfadiazine solid lipid nanoparticles for tissue repairing. Eur J Pharm Biopharm 84: 84-90.
80. Caramella CM, Bonferoni MC, Rossi S, Sandri G, Ferrari F, Perotti CG, Del Fante C,. 2011. Patent US2011280952 A1.
81. Rossi S, Faccendini A, Bonferoni MC, Ferrari F, Sandri G, Del Fante C, Perotti C, Caramella CM,. 2013. "Sponge-like" dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds. Int J Pharm 440: 207-215.
82. Gallant- Behm CL, Hildebrand KA, Hart DA,. 2008. The mast cell stabiliser ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs. Wound Repair Regen 16: 226-233.
83. Asbill CS, Mickmack BB,. 2000. Percutaneous penetration enhancers: Local versus transdermal activity. Pharm Sci Technol Today 3: 36-41.
84. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK,. 2002. Electrospun nanofibrous structure: A novel scaffold for tissue engineering. J Biomed Mater Res 60: 613-621.
85. Shah VP,. 1994. Skin penetration enhancers: Scientific perspectives. In: Drug permeation enhancement: Theory and applications;, Hsieh, DS, Ed. New York, NY: Marcel Dekker, pp 19-23.
86. Khavari PA, Rollman O, Vahlquist A,. 2002. Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252: 1-10.
87. Sprugel KH, McPherson JM, Clowes AW, Ross R,. 1987. Effects of growth factors in vivo. I. Cell in growth into porous subcutaneous chambers. Am J Pathol 129: 601-613.
88. Kootstra NA, Verma IM,. 2003. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 43: 413-39.
89. Branski LK, Gauglitz GG, Herndon DN, Jeschke MG,. 2009. A review of gene and stem cell therapy in cutaneous wound healing. Burns 35: 171-180.
90. Liechty KW, Nesbit M, Herlyn M, Radu A, Adzick NS, Crombleholme TM,. 1999. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol. 113: 375-383.
91. Galeano M, Deodato B, Altavilla D, Squadrito G, Seminara P, Marini H,. 2003. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med 31: 1017-1025.
92. Deodato B, Arsic N, Zentilin L, Galeano M, Santoro D, Torre V,. 2002. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 9: 777-785.
93. Vogel JC,. 2000. Nonviral skin gene therapy. Hum Gene Ther 11: 2253-2259.
94. Ortiz-Urda S, Thyagarajan B, Keene DR,. 2002. Stable nonviral genetic correction of inherited human skin disease. Nat Med 8: 1166-1170.
95. Eriksson E, Yao F, Svensjo T, Winkler T, Slama J, Macklin MD,. 1998. In vivo gene transfer to skin and wound by microseeding. J Surg Res 78: 85-91.
96. Eming SA, Whitsitt JS, He L, Krieg T, Morgan JR, Davidson JM,. 1999. Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 112: 297-302.
97. Felgner PL, Ringold GM,. 1989. Cationic liposome-mediated transfection. Nature 337: 387-388.
98. Jeschke MG, Barrow RE, Hawkins HK, Tao Z, Perez-Polo JR, Herndon DN,. 2000. Biodistribution and feasibility of non-viral IGF-I gene transfers in thermally injured skin. Lab Invest 80: 151-158.
99. Lee PY, Chesnoy S, Huang L,. 2004. Electroporatic delivery of TGFbeta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol 123: 791-798.
100. Flowers ME,. 1990. Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 87: 2349-2353.
101. Cairns J,. 1975. Mutation selection and the natural history of cancer. Nature 255: 197-200.
102. Han SK,. 2005. Potential of human bone marrow stromal cells to accelerate wound healing in vitro. Ann Plast Surg 55: 414-419.
103. Falanga V,. 2005. Evaluation of bilayered cell therapy for full thickness excision wounds: A multicenter, prospective, randomized, controlled trial. Wound Repair Regen 13: A4-A27.
104. Wei CJ,. 2004. Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 20: 811-838.
105. Goliger JA, Paul DL,. 1995. Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol Biol Cell 6: 1491-1501.
106. Kretz M,. 2004. Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Eur J Cell Biol 83: 647-654.
107. Richards TS,. 2004. Protein kinase C spatially and temporally regulates gap junctional communication during human wound repair via phosphorylation of connexin43 on serine368. J Cell Biol 167: 555-562.
108. Qiu C, Coutinho P, Frank S, Franke S, Law LY, Martin P, Green CR, Becker DL,. 2003. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13: 1697-1703.
109. Kapoor M,. 2005. Possible anti-inflammatory role of COX-2- derived prostaglandins: Implications for inflammation research. Curr Opin Investig Drugs 6: 461-466.
110. Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG,. 2008. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 26: 4.
111. Buyuktimkin N,. 1997. Transdermal drug permeation enhancement in transdermal and topical drug delivery systems;, Ghosh T, Yum S, Pfister W, Eds. Buffalo Grove, Illinois: Interpharm Press, pp 357-475.
112. Morghimi HR, Makmalzadeh BS, Manoti A,. 2009. Enhancement effect of terpenes on silver sulphadiazine permeation through third degree burn eschar. Burn 35: 1165-1170.
113. Quintero JA,. 2003. Patent US6547467B2.
114. Bolton L, Fattu AJ,. 1994. Topical agents and wound healing. Clin Dermatol 12: 95-120.
115. Falabella AF,. 2006. Debridgement and wound bed preparation. Dermatol Therapy 19: 317-325.
116. Purner SK, Babu M,. 2000. Collagen based dressings-A review. Burns 26: 54-62.
117. Queen D, Orsted H, Sanada H, Sussman G,. 2004. A dressing history. Int Wound J 1: 59-77.
118. Van Rijswijk L,. 2006. Ingredient based wound dressing classification, A paradigm shift that is passé and in need of replacement's wound care 15: 11-14.
119. Rosiak J, Rucinska-Rybus A, Pekala W,. 1989. Patent US4871490
120. Lawrence JC,. 1994. Dressings and wound infections. Am J Surg 167: 21S-24S.
121. Cooper R,. 2005. A review of the evidence of the use of topical antimicrobial agents in wound care. World Wound 11: 46-52.
122. Boatang JS, Pawar HV, Tetteh J,. 2013. Polyox and carrageenan based composite film dressing containing anti-microbial and anti-inflammatory drugs for effective wound healing. Int J Pharm 441: 181-191.
123. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM,. 2005. Lyophillised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity enhancer. Int J Pharm 289: 51-62.
124. Corkhill PH, Hamilton CJ, Tighe BJ,. 1989. Synthetic hydrogels. VI. Hydrogel composites as wound dressings and implant materials. Biomaterials 10: 3-10.
125. Kokabi M, Sirousazar M, Hassan ZM,. 2007. PVA-clay nanocomposite hydrogels for wound dressings. Eur Polym J 43: 773-781.
126. Churochkina NA, Staroduubstev SG, Khokhlov AR,. 1998. Swelling and collapse of the gel composite based on neutral and slightly charged poly (acrylamide) gels containing Na-montmorrillonite. Polym Gel Netw 6: 205-215.
127. Gao D, Heimann RB,. 1993. Structural and mechanical properties of superabsorbent poly (acrylamide) montmorrilonite composite hydrogels. Polym Ggel Netw 1: 225-246.
128. Lansown ABG, Jensen K, Jensen MQ,. 2003. Contreet foam and contreet hydrocolloid, an insight into two new silver-containing dressings. J Wound Care 12: 205-210.
129. Guncem G, Cigdem AO, Sibel E, Fikret S, Djunsun K, Birgul S,. 2009. Polyurethane films for wound dressing applications. J Mater Sci Mater Med 20: 421-431.
130. Queen D, Evans JH, Gaylor JDS, Courthey JM, Reid WH,. 1987. Burn wound dressings-A review. Burns 13: 218-228.
131. Sussman G,. 2010. Understanding wound films. Wound Int 1: 4.
132. Debra JB, Cheri O,. 1998. Wound healing: Technological innovations and market overview. Technology Catalysts International Corporation 2: 1-185.
133. Weller C, Sussman G,. 2006. Wound dressings update. J Pharm Prac Res 36: 318-324.
134. Lee Y-H, Chang JJ, Yang M-C, Chien C-T, Lai W-F,. 2012. Acceleration of wound healing in diabetic rats by layered hydrogel dressings. Carbohydr Polym 88: 809-819.
135. Saltzmann WM, Olbricht WL,. 2002. Building drug delivery into tissue engineering. Nat Rev Drug Discov 1: 177-186.
136. Lutolf MP, Hubbell JA,. 2005. Synthetic biomaterials as instructive extracellular microenvironment for morphogenesis in tissue engineering. Nat Biotechnol 23: 47-55.
137. Chung HJ, Park TG,. 2007. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 59: 249-262.
138. Langer R, Vacanti JP,. 1993. Tissue engineering. Science 280: 920-926.
139. Steven TB,. 1996. Cultured skin substitutes: A review. Tissue Engg 2: 255-266.
140. Hutmatcher DN,. 2000. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21: 2529-2543.
141. Vachon DJ, Yager DR,. 2006. Novel sulphonated hydrogel composite with the ability to inhibit proteases and bacterial growth. J Biomed Mater 76A: 35-43.
142. Kenawy R, Bowlin GL, Mansfield K, Laymann J, Simpson DG, Sanders EH, Wnek GE,. 2002. Release of tetracycline hydrochloride from electrospin poly(ethylene-co-vinylacetate) poly(lactic acid) and a blend. J Control Rel 81: 57-64.
143. Khil MS, Cha DI, Kim HY, Kim IS, Battaria N,. 2003. Electrospun nanofibrous polyurethane membranes as wound dressings. J Biomed Mater Res B Appl Biom 67: 675-679.
144. Thakur RA, Florek CA, Kohn J, Michniak BB,. 2008. Electrospun nanofibre scaffold with targeted drug release profiles for potential applications as wound dressings. Int J Pharm 364: 87-93.
145. Peter SJ, Miller MJ, Yasko AW, Yazemski MJ, Mikos AG,. 1998. Polymer concepts in tissue engineering. J Biomed Mater Res B Appl Biomater 43: 422-427.
146. Diegelmann RF, Evans MC,. 2004. Wound healing: An overview of acute, fibrotic and delayed healing. Frontier Biosci 9: 283-289.
147. Senet P,. 2004. Becaplermin gel (Regranex gel). Ann Dermatol Venereol 13: 351-358.
148. Steffansen B, Herping SPK,. 2008. Novel wound models for characterising ibuprofen release from foam dressings. Int J Pharm 364: 150-155.
149. Miyoshi M, Kavaizoe T, Igawa HH, Tabata Y, Ikada Y, Suzuki S,. 2006. Effects of bFGF incorporated into a gelatin sheet on wound healing J Biomater Sci Polym 16: 893-907.
150. Kumar P, Choonara YE, Modi G, Naidoo D, Pillay V,. 2014. Nanoparticulate strategies for the 5 R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine 9: 331-348.
151. Bishop SM, Griffith B, Linnane PG, Lydon MJ, Shaw H,. 2010. Patent US7759537B2.
152. Horber JKH, Miles MJ,. 2003. Scanning probe evolution in biology. Science 302: 1002-1005.
153. Dersch R, Steinhart M, Boudriot U, Greiner A, Wendorff JH,. 2005. Nanoprocessing of polymers: applications in medicine, sensors, catalysis, photonics. Polym Adv Tech 16: 276-282.
154. Wolf NB, Küchler S, Radowski MR, Blaschke T, Kramer KD, Weindl G, Kleuser B, Haag R, Schäfer-Korting M,. 2009. Influences of opioids and nanoparticles on in vitro wound healing models. Eur J Pharm Biopharm 73: 34-42.
155. Bhuveneshwari T, Thiyagarajan M, Geetha N, Venkatachalam P,. 2014. Bioactive compound loaded stable silver nanoparticle synthesis from microwave irradiated aqueous extracellular leaf extracts of Naringi crenulata and its wound healing activity in experimental rat model. Acta Trop 135: 55-61.
156. Christian P, Von der Kammer F, Baalousha M, Hofmann T,. 2008. Nanoparticles: Structure, properties, preparation and behaviour in environmental media. Ecotoxicology 17: 326-343.
157. Losi P, Briganti E, Errico C, Lisella A, Sanguinetti E, Chiellini F, Soldani G,. 2013. Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice. Acta Biomater 9: 7814-7821.
158. Hendi A,. 2011. Silver nanoparticles mediate differential responses in some of liver and kidney functions during skin wound healing. J King Saud Univ (Sci) 23: 47-52.
159. Gopal A, Kant V, Gopalakrishnan A, Tandan SK, Kumar D,. 2014. Molecular and cellular pharmacology: Chitosan-based copper nanocomposite accelerates healing in excision wound model in rats. Eur J Pharmacol 731: 8-19.
160. Wu J, Zheng Y, Song W, Luan J, Wen X, Wu Z, Chen X, Wang Q, Guo S,. 2014. In situ synthesis of silver-nanoparticles/bacterial cellulose composites for slow-released antimicrobial wound dressing. Carbohydr Polym 102: 762-771.
161. Huang Z-M, Zhang Y-Z, Khotalo M, Ramakrishna S,. 2003. A review on polymer nanofibres by electrospinning and their applications in nanocomposites. Composit Sci Technol 63: 2223-2253.
162. Agarwal S, Wendorff JH, Greiner A,. 2008. Use of electrospinning technique for biomedical applications. Polymer 49: 5603-5621.
163. Luu YK, Kim K, Hsiao BS, Chu B, Hadijiargyrou M,. 2003. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymer. J Control Release 289: 341-353.
164. Yoshimoto H, Shin YM, Terai H, Vacanti JP,. 2003. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 27: 2077-2082.
165. Pillay V, Dott C, Choonara YE, Tyagi C, Tomar L, Kumar P, du Toit LC, Ndesendo VMK,. 2013. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J Nanomater 2013: 789289.
166. Mattews JA, Wnek GE, Simpson DG, Bowlin GL,. 2002. Electrospinning of collagen nanofibers. Biomacromolecules 3: 232-238.
167. Chow YS, Lee JW, Lee JS, Lee JH, Yoon TR, Kuroyanagi Y, Park MH, Pyun DG, Kim HJ,. 2002. Hyaluranic acid and silver sulfadiazine impregnated polyurethane for wound dressing applications. J Mater Sci Mater Med 13: 861-865.
168. Flemming RG, Murphy CJ, Abrams GA, Goodman SL, Nealey PF,. 1999. Effects of synthetic micro- and nano-structured surfaces on cell behaviour. Biomaterials 20: 573-588.
169. Green IS, Jansen JA, van der Waerden JP, von Recum AF,. 1994. Fibroblast response to microtextured silicone surfaces: Texture orientation into or out of the surface. J Biomed Mater Res 28: 647-653.
170. Su Rho K, Jeong L, Lee G, Seo B-M, Park YJ, Hong S-B, Roh S, Cho JJ, Park WH, Min B-M,. 2006. Electrospinning of collagen nanofibres: Effects on the behaviour of normal keratinocytes and early stage wound healing. Biomaterials 27: 1452-1461.